Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Phase I/II Gene Therapy Study for Chronic Granulomatous Disease: Results, Lessons and Perspectives.

Blood (2007) 110 (11): 503.

https://doi.org/10.1182/blood.V110.11.503.503

Published: 2007

Journal Articles

Long-Term Clinical Follow-Up and Safety/Toxicity Analysis in 3 X-CGD Patients Treated by Gene Therapy and Non-Myeloablative Conditioning.

Marion G. Ott, MD, Manfred Schmidt, PhD, Stefan Stein, PhD, Kerstin Schwarzwaelder, Ulrich Siler, PhD, Ulrike Koehl, PhD, Klaus Kuehlcke, PhD, Andrea Schilz, PhD, Christoph v. Kalle, PhD, Dieter Hoelzer, MD, Reinhard Seger, MD, Manuel Grez, PhD

Blood (2006) 108 (11): 199.

https://doi.org/10.1182/blood.V108.11.199.199

Published: 2006

Journal Articles

A ComParison of Retroviral Integration Sites in Donor T-Lymphocytes In Vivo and In Vitro.

Frank A. Giordano, Stephanie Laufs, Boris Fehse, K. Zsuzsanna Nagy, Agnes Hotz-Wagenblatt, Daniel Lauterborn, Kurt Fellenberg, Klaus Kuehlcke, Sonja Naundorf, Axel R. Zander, W. Jens Zeller, Stefan Fruehauf

Blood (2005) 106 (11): 1403.

https://doi.org/10.1182/blood.V106.11.1403.1403

Published: 2005

Journal Articles

Long-Term Follow-Up of Patients Treated by Gene Therapy for X-Linked Chronic Granulomatous Disease.

Marion G. Ott, MD, Manuel Grez, PhD, Stefan Stein, PhD, Ulrich Siler, PhD, Ulrike Koehl, PhD, Klaus Kuehlcke, PhD, Manfred Schmidt, MD, Andrea Schilz, PhD, Hana Kunkel, Sonja Naundorf, PhD, Andrea Brinkmann, Moustapha Hassan, PhD, Christof von Kalle, MD, Adrian Trasher, MD, Reinhard Seger, MD, Dieter Hoelzer, MD

Blood (2005) 106 (11): 194.

https://doi.org/10.1182/blood.V106.11.194.194

Published: 2005

Journal Articles

Leukemias following retroviral transfer of multidrug resistance 1 ( MDR1 ) are driven by combinatorial insertional mutagenesis

Ute Modlich, Olga S. Kustikova, Manfred Schmidt, Cornelia Rudolph, Johann Meyer, Zhixiong Li, Kenji Kamino, Nils von Neuhoff, Brigitte Schlegelberger, Klaus Kuehlcke, Kevin D. Bunting, Sonja Schmidt, Annette Deichmann, Christof von Kalle, Boris Fehse, Christopher Baum

Blood (2005) 105 (11): 4235–4246.

https://doi.org/10.1182/blood-2004-11-4535

Published: 2005

Journal Articles

Profiling Retroviral Integration Sites in Donor T-Lymphocytes for Suicide Gene Therapy.

Frank A. Giordano, Stephanie Laufs, Katalin Z. Nagy, Boris Fehse, Agnes Hotz-Wagenblatt, Daniel Lauterborn, Kurt Fellenberg, Klaus Kuehlcke, Sonja Naundorf, Axel R. Zander, Jens W. Zeller, Stefan Fruehauf

Blood (2004) 104 (11): 1744.

https://doi.org/10.1182/blood.V104.11.1744.1744

Published: 2004

Journal Articles

Retroviral vector integration occurs in preferred genomic targets of human bone marrow–repopulating cells

Stephanie Laufs, Bernhard Gentner, K. Zsuzsanna Nagy, Anna Jauch, Axel Benner, Sonja Naundorf, Klaus Kuehlcke, Bernhard Schiedlmeier, Anthony D. Ho, W. Jens Zeller, Stefan Fruehauf

Blood (2003) 101 (6): 2191–2198.

https://doi.org/10.1182/blood-2002-02-0627

Published: 2003

NARROW

Phase I/II Gene Therapy Study for Chronic Granulomatous Disease: Results, Lessons and Perspectives.

Long-Term Clinical Follow-Up and Safety/Toxicity Analysis in 3 X-CGD Patients Treated by Gene Therapy and Non-Myeloablative Conditioning.

A ComParison of Retroviral Integration Sites in Donor T-Lymphocytes In Vivo and In Vitro.

Long-Term Follow-Up of Patients Treated by Gene Therapy for X-Linked Chronic Granulomatous Disease.

Leukemias following retroviral transfer of multidrug resistance 1 ( MDR1 ) are driven by combinatorial insertional mutagenesis

Profiling Retroviral Integration Sites in Donor T-Lymphocytes for Suicide Gene Therapy.

Retroviral vector integration occurs in preferred genomic targets of human bone marrow–repopulating cells

Email alerts

ASH Publications

American Society of Hematology

Phase I/II Gene Therapy Study for Chronic Granulomatous Disease: Results, Lessons and Perspectives.

Long-Term Clinical Follow-Up and Safety/Toxicity Analysis in 3 X-CGD Patients Treated by Gene Therapy and Non-Myeloablative Conditioning.

A ComParison of Retroviral Integration Sites in Donor T-Lymphocytes In Vivo and In Vitro.

Long-Term Follow-Up of Patients Treated by Gene Therapy for X-Linked Chronic Granulomatous Disease.

Leukemias following retroviral transfer of multidrug resistance 1 ( MDR1 ) are driven by combinatorial insertional mutagenesis

Profiling Retroviral Integration Sites in Donor T-Lymphocytes for Suicide Gene Therapy.

Retroviral vector integration occurs in preferred genomic targets of human bone marrow–repopulating cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only